| Complete replication of hepatitis C virus in cell culture BD Lindenbach, MJ Evans, AJ Syder, B Wolk, TL Tellinghuisen, CC Liu, ... Science 309 (5734), 623-626, 2005 | 2800 | 2005 |
| Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry MJ Evans, T Von Hahn, DM Tscherne, AJ Syder, M Panis, B Wölk, ... Nature 446 (7137), 801-805, 2007 | 1676 | 2007 |
| Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication KJ Blight, JA McKeating, CM Rice Journal of virology 76 (24), 13001-13014, 2002 | 1415 | 2002 |
| Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus … JV Giorgi, LE Hultin, JA McKeating, TD Johnson, B Owens, LP Jacobson, ... The Journal of infectious diseases 179 (4), 859-870, 1999 | 1326 | 1999 |
| Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles M Hsu, J Zhang, M Flint, C Logvinoff, C Cheng-Mayer, CM Rice, ... Proceedings of the National Academy of Sciences 100 (12), 7271-7276, 2003 | 1040 | 2003 |
| EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy J Lupberger, MB Zeisel, F Xiao, C Thumann, I Fofana, L Zona, C Davis, ... Nature medicine 17 (5), 589-595, 2011 | 841 | 2011 |
| Dissociation of gp120 from HIV-1 virions induced by soluble CD4 JP Moore, JA McKeating, RA Weiss, QJ Sattentau Science 250 (4984), 1139-1142, 1990 | 787 | 1990 |
| Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge M Law, T Maruyama, J Lewis, E Giang, AW Tarr, Z Stamataki, ... Nature medicine 14 (1), 25-27, 2008 | 676 | 2008 |
| Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81 M Flint, C Maidens, LD Loomis-Price, C Shotton, J Dubuisson, P Monk, ... Journal of virology 73 (8), 6235-6244, 1999 | 623 | 1999 |
| Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro BD Lindenbach, P Meuleman, A Ploss, T Vanwolleghem, AJ Syder, ... Proceedings of the National Academy of Sciences 103 (10), 3805-3809, 2006 | 566 | 2006 |
| Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR S Pöhlmann, J Zhang, F Baribaud, Z Chen, GJ Leslie, G Lin, ... Journal of virology 77 (7), 4070-4080, 2003 | 561 | 2003 |
| Neutralizing antibody response during acute and chronic hepatitis C virus infection C Logvinoff, ME Major, D Oldach, S Heyward, A Talal, P Balfe, ... Proceedings of the National Academy of Sciences 101 (27), 10149-10154, 2004 | 556 | 2004 |
| Time-and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry DM Tscherne, CT Jones, MJ Evans, BD Lindenbach, JA McKeating, ... Journal of virology 80 (4), 1734-1741, 2006 | 522 | 2006 |
| Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo T Von Hahn, JC Yoon, H Alter, CM Rice, B Rehermann, P Balfe, ... Gastroenterology 132 (2), 667-678, 2007 | 519 | 2007 |
| CD81 is required for hepatitis C virus glycoprotein-mediated viral infection J Zhang, G Randall, A Higginbottom, P Monk, CM Rice, JA McKeating Journal of virology 78 (3), 1448-1455, 2004 | 501 | 2004 |
| MAIT cells are activated during human viral infections B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ... Nature communications 7 (1), 11653, 2016 | 475 | 2016 |
| Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture KJ Blight, JA McKeating, J Marcotrigiano, CM Rice Journal of virology 77 (5), 3181-3190, 2003 | 474 | 2003 |
| Hepatitis C virus cell‐cell transmission in hepatoma cells in the presence of neutralizing antibodies JM Timpe, Z Stamataki, A Jennings, K Hu, MJ Farquhar, HJ Harris, ... Hepatology 47 (1), 17-24, 2008 | 468 | 2008 |
| Viral hepatitis and liver cancer M Ringehan, JA McKeating, U Protzer Philosophical Transactions of the Royal Society B: Biological Sciences 372 …, 2017 | 402 | 2017 |
| Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4 … JP Moore, JA McKeating, YX Huang, A Ashkenazi, DD Ho Journal of virology 66 (1), 235-243, 1992 | 376 | 1992 |
